%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/2162402X.2018.1532763
Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model
Lukasz Kuryk
Anne-Sophie W. Møller
Magnus Jaderberg
Taylor & Francis
OncoImmunology, 2018. doi:10.1080/2162402X.2018.1532763
ONCOS-102
Pembrolizumab
melanoma
NOG
immunogenic cell death
PD-1 inhibitor
antitumor
cancer vaccine
oncolytic adenovirus
en
Journal
OncoImmunology
© 2018 The Author(s). Published with license by Taylor & Francis Group, LLC.
2162-402X
00
00
1
11
10.1080/2162402X.2018.1532763
https://doi.org/10.1080/2162402X.2018.1532763
VoR
application/pdfdoi:10.1080/2162402X.2018.153276310.1080/2162402X.2018.1532763https://doi.org/10.1080/2162402X.2018.15327632018-10-29truewww.tandfonline.com10.1080/2162402X.2018.1532763www.tandfonline.comtrue2018-10-2910.1080/2162402X.2018.1532763
endstream
endobj
4 0 obj
<>stream
xɎ,9_?*a4'@Å'"a;{jeK8~yoU_>?ӰAtq+1,~71lm<ZiCckz^WzxFpZEwoWzz{m^7FOÎ>sq R>?}.@l"<0'% . ɞ-zf+[o},;!PʔIWd?E3auW`@NaD+@!t?=}(f vajrZ+ͦMG/S'|.wo1=}==s|$Tji<(Dh dVo~?ʝX4unKYr1g:! ]]m@gC{03f[T#!PX^Z7~zPU]~ {%:>
k gy]`X:t3{B.Jm$3((QuB4-uX/-u+¼$c5v꒶ǃ%h))_ǔSC]~b=<~%< V> m$GY@q0lZ7eh.S,nPQc[3U42C⸧4YNiI.5}&18!!64/G5g5_V Lp3gȗF{sԜ]yzQr5 UM9M ;3A_AHj'I}Dt߆Xp